- Home
- CNL vs SYRE Comparison
CNL vs SYRE Comparison
Compare CNL & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNL
- SYRE
- Stock Information
- Founded
- CNL 2018
- SYRE 2013
- Country
- CNL Canada
- SYRE United States
- Employees
- CNL N/A
- SYRE N/A
- Industry
- CNL
- SYRE Biotechnology: Pharmaceutical Preparations
- Sector
- CNL
- SYRE Health Care
- Exchange
- CNL NYSE
- SYRE Nasdaq
- Market Cap
- CNL 871.3M
- SYRE 841.4M
- IPO Year
- CNL N/A
- SYRE 2016
- Fundamental
- Price
- CNL $9.75
- SYRE $15.01
- Analyst Decision
- CNL Strong Buy
- SYRE Buy
- Analyst Count
- CNL 1
- SYRE 6
- Target Price
- CNL $8.00
- SYRE $55.00
- AVG Volume (30 Days)
- CNL 62.2K
- SYRE 521.8K
- Earning Date
- CNL 01-01-0001
- SYRE 08-06-2025
- Dividend Yield
- CNL N/A
- SYRE N/A
- EPS Growth
- CNL N/A
- SYRE N/A
- EPS
- CNL N/A
- SYRE N/A
- Revenue
- CNL N/A
- SYRE N/A
- Revenue This Year
- CNL N/A
- SYRE N/A
- Revenue Next Year
- CNL N/A
- SYRE N/A
- P/E Ratio
- CNL N/A
- SYRE N/A
- Revenue Growth
- CNL N/A
- SYRE N/A
- 52 Week Low
- CNL $2.43
- SYRE $10.91
- 52 Week High
- CNL $12.00
- SYRE $40.26
- Technical
- Relative Strength Index (RSI)
- CNL N/A
- SYRE 42.53
- Support Level
- CNL N/A
- SYRE $13.93
- Resistance Level
- CNL N/A
- SYRE $18.01
- Average True Range (ATR)
- CNL 0.00
- SYRE 1.14
- MACD
- CNL 0.00
- SYRE -0.26
- Stochastic Oscillator
- CNL 0.00
- SYRE 20.49
About CNL COLLECTIVE MINING LTD
Collective Mining Ltd is an exploration and development company focused on identifying and exploring prospective mineral projects in South America. The company currently has interest in two projects located in Colombia, namely, Guayabales and San Antonio. The company is responsible for discovering, permitting, and constructing the gold mine in Colombia. The company is rapidly advancing exploration on large-scale copper-gold-molybdenum porphyry targets in the mining-friendly department of Caldas in Colombia. Drilling is underway at the Guayabales project which is strategically located contiguous to the Marmato deposit, with initial assay results ongoing.
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.